Sensenig Bethany
CIK 0001899935
Chief Financial OfficerDirector
Filings
12
Latest Apr 17, 2026
Issuers covered
4
Showing
12 of 12
Page 1
Track record
3 of 4 open-market trades scored (75% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | +1.3% | +4.1% | +4.1% | -4.3% |
| 90 days | 3 | 67% | +1.5% | +5.2% | +5.2% | -5.8% |
| 180 days | 1 | 0% | -21.4% | -21.4% | -21.4% | -21.4% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Sensenig Bethany has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SUPN | Supernus Pharmaceuticals, Inc. | 7 | Feb 23, 2026 |
| NMTR | 9 Meters Biopharma, Inc. | 3 | Apr 21, 2023 |
| ACOG | Alpha Cognition Inc. | 1 | Apr 17, 2026 |
| KALV | Kalvista Pharmaceuticals, Inc. | 1 | Oct 2, 2025 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|